News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
PET-adapted BrECADD versus escBEACOPP in Hodgkin Lymphoma
Aug 1, 2024, 03:07

PET-adapted BrECADD versus escBEACOPP in Hodgkin Lymphoma

Graham Collins, Associate Professor, Haematology and lymphoma specialist at Oxford Cancer and Haematology centre, shared a paper by Peter Borchmann et al. on X, adding:

“Front line treatment of Hodgkin Lymphoma with PET-adapted BrECADD versus escBEACOPP. BrECADD wins the day.

Can it be beaten…?”

Source: Graham Collins/X

Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial.

Authors: Peter Borchmann, Justin Ferdinandus, Gundolf Schneider, Alden Moccia, Richard Greil, Mark Hertzberg, Valdete Schaub, Andreas Hüttmann, Felix Keil, Judith Dierlamm, Mathias Hänel, Urban Novak, Julia Meissner, Andreas Zimmermann, Stephan Mathas, Josée M Zijlstra, Alexander Fosså, Andreas Viardot, Bernd Hertenstein, Sonja Martin, Pratyush Giri, Sebastian Scholl, Max S Topp, Wolfram Jung, Vladan Vucinic, Hans-Joachim Beck, Andrea Kerkhoff, Benjamin Unger, Andreas Rank, Roland Schroers, Christian Meyer zum Büschenfelde, Maike de Wit, Karolin Trautmann-Grill, Peter Kamper, Daniel Molin, Stefanie Kreissl, Helen Kaul, Dipl-Math,  Bastian von Tresckow, Sven Borchmann, Karolin Behringer, Michael Fuchs, Andreas Rosenwald, Wolfram Klapper, L Hans-Theodor Eich, Christian Baues, Athanasios Zomas, Michael Hallek, Markus Dietlein, Carsten Kobe, and Volker Diehl.

BrECADD

Alden Moccia Alexander Fosså Andrea Kerkhoff Andreas Hüttmann Andreas Rank Andreas Rosenwald Andreas Viardot Andreas Zimmermann Athanasios Zomas Bastian von Tresckow Benjamin Unger Bernd Hertenstein BrECADD cancer Carsten Kobe Christian Baues Christian Meyer zum Büschenfelde Daniel Molin Dipl-Math escBEACOPP Felix Keil Graham Collins Gundolf Schneider Hans-Joachim Beck Helen Kaul Hodgkin lymphoma Josée M Zijlstra Judith Dierlamm Julia Meissner Justin Ferdinandus Karolin Behringer Karolin Trautmann-Grill L Hans-Theodor Eich Maike de Wit Mark Hertzberg Markus Dietlein Mathias Hänel Max S Topp Michael Fuchs Michael Hallek OncoDaily Oncology Peter Borchmann Peter Kamper Pratyush Giri Richard Greil Roland Schroers Sebastian Scholl Sonja Martin Stefanie Kreissl Stephan Mathas Sven Borchmann Urban Novak Valdete Schaub Vladan Vucinic Volker Diehl Wolfram Jung Wolfram Klapper
Special Coverage
Blog
Nov 1, 2024, 20:27
Amy Oxentenko: Honored to be inducted as President of the American College of Gastroenterology
Blog
Nov 1, 2024, 20:22
Yan Leyfman: Honored to present our research at the 2024 Lymphoma, Leukemia and Myeloma Congress
Blog
Nov 1, 2024, 20:05
The Official Programme for Advancing Paediatric Oncology on Children’s Rights Day is Out - SIOP Europe
Blog
Nov 1, 2024, 19:20
Chandler Park: Dr. Petros Grivas answers the most important question for junior faculty
Blog
Nov 1, 2024, 19:12
ESTRO: Toxicity Profile of Immune Therapy Combined with Radiotherapy
Insight
Nov 1, 2024, 17:59
Ajay Major: Collect long-term follow-up data in survivors of Hodgkin lymphoma with the MyHodgkin MyHealth app
Blog
Nov 1, 2024, 17:52
Habib Nehmé: Strengthening Presence in Saudi Arabia’s Radiotherapy and Oncology Market
Blog
Nov 1, 2024, 17:46
Hidehito Horinouchi: Early Stage NSCLC at ACLC24 session
Blog
Nov 1, 2024, 17:41
Yelak Biru's interview with News 9 about the work IMF does
Insight
Nov 1, 2024, 17:31
Francisco Esteva: ADCs are making waves in the fight against advanced HER2+ breast cancer
Blog
Nov 1, 2024, 17:27
Alcohol consumption increases the risk of cancer at 7 sites - IARC
Blog
Nov 1, 2024, 17:17
Raul Cordoba: Valemetostat for relapsed or refractory peripheral T-cell lymphoma